Migraine Articles
NMT MEDICAL ANNOUNCES SIGNIFICANT CHANGES TO ITS CLINICAL TRIAL PLANS IN THE UNITED STATES
Headache / Migraine News From Medical News Today,
January 25, 2008
Comments
NMT Medical, Inc. (NASDAQ: NMTI) nnounced that the Company is closing down its patent foramen ovale (PFO)/migraine trial, MIST II, to focus its resources on its PFO/stroke opportunity. The move is expected to save the Company approximately $14 million over the next two to three years as it redistributes investments originally budgeted ...
MOBILE EFFECT ON SLEEP
Headache / Migraine News From Medical News Today,
January 22, 2008
Comments
"Radiation from mobile phones delays and reduces sleep, and causes headaches and confusion, according to a new study", reported The Independent on Sunday on January 20 2008. The Daily Telegraph also covered the story, reporting that a study funded by handset manufacturers found that using a mobile before going to bed could damage your...
BENIGN BRAIN TUMORS
MedicineNet Migraine General,
January 18, 2008
Comments
Title: Benign Brain Tumors
Category: Doctor's Views
Created: 1/18/2008
Last Editorial Review: 1/18/2008
POZEN SUBMITS HUMAN LYMPHOCYTE STUDY FOR TREXIMET™ (FORMERLY KNOWN AS TREXIMA™)
Headache / Migraine News From Medical News Today,
January 17, 2008
Comments
POZEN Inc. (NASDAQ: POZN) announced that it has submitted the findings from the short-term human volunteer study of the genotoxic potential of Treximet™ (formerly known as Trexima™) to the U.S. Food and Drug Administration (FDA).
MAP PHARMACEUTICALS REACHES AGREEMENT WITH FDA ON SPECIAL PROTOCOL ASSESSMENT FOR MAP0004 PHASE 3 CL
Headache / Migraine News From Medical News Today,
January 17, 2008
Comments
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP), an emerging pharmaceutical company, announced that it has completed the special protocol assessment (SPA) process with the U.S. Food and Drug Administration (FDA) for the first Phase 3 clinical trial of its MAP0004 product candidate, and has reached agreement with the Agency on the design of th...
All information offered on this site is for educational purposes only and should not be construed as medical advice, diagnosis, or treatment.
